Desmopressin nasal spray has been recognized in the literature as a successful treatment for nocturnal enuresis in patients on clozapine [1–5]. No serious adverse reactions have been previously reported in this population. This paper reports a case of severe hyponatraemia in a 47-year-old man with schizophrenia who was commenced on desmopressin nasal spray to treat clozapineinduced nocturnal enuresis. To our knowledge, this is the first such case report.
|Number of pages||1|
|Journal||Australian and New Zealand Journal of Psychiatry|
|Publication status||Published - Oct 2005|